These data demonstrate that the high DYRK1A protein levels are retained at relapse and are overall elevated in KMT2A-R ALL compared to Ph-like ALL (Supplementary Fig. 1H). The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.